论文部分内容阅读
Background and aims Myosin light chain kinase (MLCK) plays a central role in the mechanisms of barrier dysfunction, and a lot of studies showed the intestinal barrier permeability increased in nonalcoholic fatty liver disease (NAFLD).The research aimed to identify whether MLCK was a regulator in the intestinal barrier permeability change of nonalcoholic fatty liver disease (NAFLD).